Transcranial focused ultrasound stimulation in schizophrenia: current evidence, mechanisms, and future directions - Summary - MDSpire

Transcranial focused ultrasound stimulation in schizophrenia: current evidence, mechanisms, and future directions

  • By

  • Chunyang Shi

  • Qing Zhao

  • Gang Zhang

  • Zhoubing Wang

  • Jun Zhou

  • Xianlu Chang

  • Ziming Liao

  • Wanying Zhang

  • Huihua Li

  • Huiying Xue

  • Kexu Zhang

  • Xiong Jiao

  • Junfeng Sun

  • Qiang Hu

  • July 6, 2026

  • 0 min

Share

Objective:

To synthesize available preclinical and clinical evidence on transcranial focused ultrasound stimulation (tFUS) in schizophrenia, focusing on mechanisms, safety, stimulation targets, methodological limitations, and translational challenges.

Approach:
  • Literature Review: A structured literature search was conducted across PubMed, Web of Science, and PsycINFO to gather evidence on tFUS in schizophrenia, including preclinical and clinical studies.
Key Findings:
  • tFUS has shown potential in reversing cognitive deficits and preventing psychotic-like behaviors in rodent models, restoring parvalbumin-positive GABAergic interneuron markers in the prefrontal cortex, and upregulating NMDA receptor-related signaling.
  • Early clinical studies indicate that tFUS is feasible and generally well tolerated in patients with schizophrenia.
  • Targets for tFUS include the dorsolateral prefrontal cortex for negative symptoms, the globus pallidus/globus pallidus internus for sensory gating-related circuits, and striatal circuits for auditory hallucinations.
  • Efficacy data from clinical studies remain preliminary and require further investigation.
Interpretation:

Current evidence is insufficient to support definitive clinical conclusions regarding the therapeutic potential of tFUS in schizophrenia.

Limitations:
  • Bone-conducted auditory confounds may affect blinding.
  • Incomplete and heterogeneous reporting of stimulation parameters.
  • Small sample sizes and short follow-up periods.
  • Limited evidence for durable clinical benefits.
Conclusion:

Larger, well-controlled studies are required to better understand the therapeutic potential of tFUS in schizophrenia.

Original Source(s)

Related Content